AC
ACHV icon

AXQ Capital’s Achieve Life Sciences ACHV Stock Holding History

AXQ Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
25,173
+9,972
+66% +$47.6K 0.02% 749
2026
Q1 		$44.7K Buy
+15,201
New +$67.5K 0.01% 936

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AXQ Capital's ACHV Position: Q2 2026 in Review

AXQ Capital increased its Achieve Life Sciences (ACHV) stake by 66% in Q2 2026, buying an estimated $47.6K and bringing the position to 25,173 shares worth $164K. The position accounts for 0.02% of the portfolio, ranked #749.

AXQ Capital first reported a position in ACHV in Q1 2026 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • AXQ Capital held 25,173 shares of Achieve Life Sciences worth $164K as of Q2 2026.
  • AXQ Capital bought 9,972 Achieve Life Sciences shares in Q2 2026, an estimated $47.6K.
  • Achieve Life Sciences made up 0.02% of AXQ Capital's portfolio in Q2 2026, its #749 holding.
  • AXQ Capital first reported a position in Achieve Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.